Key Takeaways:
- Abbott Laboratories (ABT, Financial) misses Q3 EPS guidance, affecting stock performance.
- Analysts see potential upside with an average price target of $143.47.
- GF Value suggests a possible downside, highlighting mixed investment signals.
Abbott Laboratories' Recent Performance
Abbott Laboratories (ABT) has seen a notable ~5% decline in premarket trading after releasing its third-quarter guidance, which did not meet market expectations. The company anticipates adjusted EPS to range between $1.28 and $1.32, slightly below the consensus estimate of $1.33. Nevertheless, the company’s full-year outlook remains in line with analyst projections. While certain segments reported robust revenue figures, the underperformance of the Diagnostics division weighed down overall results.
Analyst Price Targets and Recommendations
Wall Street analysts have established a one-year price target outlook for Abbott Laboratories (ABT, Financial) that averages at $143.47, with projections ranging from a high of $159.00 to a low of $120.12. This average target indicates a potential upside of 8.90% from the current trading price of $131.74. Investors can access more comprehensive estimate data by visiting the Abbott Laboratories (ABT) Forecast page.
Currently, based on the consensus from 29 brokerage firms, Abbott Laboratories holds an average brokerage recommendation of 2.1 on the rating scale, categorizing it as "Outperform." This scale ranges from 1, representing a Strong Buy, to 5, indicating a Sell recommendation.
GF Value Insights
GuruFocus has gauged the estimated GF Value for Abbott Laboratories (ABT, Financial) at $121.36 over the next year. This suggests a downside potential of 7.88% from the current price point of $131.74. The GF Value metric reflects GuruFocus' assessment of the fair trading value for the stock, which is derived from historical trading multiples as well as projections of future business performance. For a more extensive analysis, investors are encouraged to visit the Abbott Laboratories (ABT) Summary page.
